French Rival Said to Be Considering Aventis for Takeover

Article Abstract:

The French pharmaceutical company Sanofi-Synthelabo may acquire Aventis Pharmaceuticals for approximately $60 billion, thus making it the third largest drug company after Pfizer and GlaxoSmithKline. Sanofi, well known for its products Ambien and Plavix, is working on its bidding strategy to avoid a hostile takeover. Aventis maintains that no discussions are underway at this time for a merger.

Italy, Aventis Pharmaceuticals Inc., Sanofi-Sythelabo

---

Sanofi Makes Its Bid for Aventis;It Is Quickly Rejected as 'Inferior'

Article Abstract:

Sanofi-Synthelabo's $60 billion bid for Aventis S.A. was rejected because it was considered an undervalued offer. The French government supports the offer despite the possibility that many layoffs will take place. The offer includes five shares of Sanofi and 69 euros for every six shares of Aventis. GlaxoSmithKline and Novartis are possible contenders but they have not yet made an offer.

France, Aventis S.A., AVE, Sanofi Synthelabo

---

Bristol-Myers Seeks to Sell Excedrin Line

Article Abstract:

Bristol-Meyers Squibb Co. plans to sell its consumer medicines division, which analysts believe is worth between $700 million and $1 billion. The company will use the assets from the sale to focus on its pharmaceutical division.

Organizational history, Pharmaceutical preparations, Company restructuring/company reorganization, Reorganization and restructuring, Bristol-Myers Squibb Co., BMY, Nonprescription drugs, Company organization

Similar abstracts:

• Abstracts: Osprey about to join trust craze: Newspaper group formed from former Hollinger papers to go public in weeks. Teachers agrees to WestJet investment
• Abstracts: Oil and the president's men. Bush's time trip
• Abstracts: Parmalat Canada expected to draw bidders: observers expect division to be sold. Stench of scandals lingers: Aroma wafting from Italy is the now familiar scent of corporate rot that shows no sign of abating
• Abstracts: Exchange Said To Want Move On Grasso Pay. A Jury Assesses Morgan Stanley $604 Million. States vs. U.S.: Who Will Police Insurance Firms?
• Abstracts: After the Deal: A Crucial Merger of Styles. The Architect Behind Kmart's Surprising Takeover of Sears. Managing Money by Sizing Up Corporate Chiefs

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.